VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 8, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM - News) announced today that the Company's President and Chief Executive Officer, Dr. Mark Murray, will present a corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009 at 4:05 pm ET at the New York Palace Hotel in New York City. A live webcast of the presentation will be available and can be accessed on the Company's website, www.tekmirapharm.com.
Dr. Murray will also participate in a panel discussion on RNAi Therapeutics at the Rodman & Renshaw conference taking place Thursday, September 10, 2009 at 8:25 am ET.
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
Adam Peeler
The Equicom Group - Investors
416-815-0700 x 225
apeeler@equicomgroup.com
Ian Mortimer
Tekmira Pharmaceuticals Corporation - Investors
Executive Vice President and Chief Financial Officer
604-419-3200
www.tekmirapharm.com
David Ryan
Longview Communications Inc. - Media
604-694-6031
dryan@longviewcomms.ca
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.